Cargando…

Vitamin B12, Folates, and Docosahexaenoic Acid on the Prevention of Neuronal Dysfunction

OBJECTIVES: Global aging increases cognitive pathologies; however, some individuals present earlier symptoms with an etiology independent of age. A possible cause is the increased oxidative stress with the formation of amyloid fibrils in the neuronal tissue (in particular Aβ(1–40|42)). Studies use A...

Descripción completa

Detalles Bibliográficos
Autores principales: Motta, Carla, Furtado, José, Rego, Andreia, Cardoso, Carlos, Afonso, Claúdia, Bandarra, Narcisa, Prates, José, Castanheira, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194004/
http://dx.doi.org/10.1093/cdn/nzac074.022
_version_ 1784726610619924480
author Motta, Carla
Furtado, José
Rego, Andreia
Cardoso, Carlos
Afonso, Claúdia
Bandarra, Narcisa
Prates, José
Castanheira, Isabel
author_facet Motta, Carla
Furtado, José
Rego, Andreia
Cardoso, Carlos
Afonso, Claúdia
Bandarra, Narcisa
Prates, José
Castanheira, Isabel
author_sort Motta, Carla
collection PubMed
description OBJECTIVES: Global aging increases cognitive pathologies; however, some individuals present earlier symptoms with an etiology independent of age. A possible cause is the increased oxidative stress with the formation of amyloid fibrils in the neuronal tissue (in particular Aβ(1–40|42)). Studies use Aβ(25–35) fragment to form β sheet fibrils with a toxicity similar to Aβ(1–40|42). Converging studies sustain the idea that B12, B9, and docosahexaenoic may preserve regular neuronal activity. However, the literature is scarce about their synergy effects. The study aims to verify the hypothesis of reducing cellular apoptosis, using B12, B9, and docosahexaenoic acid (DHA) as preventives, isolated or in synergy, on delaying neuronal dysfunction, using “in vitro” assays. METHODS: An In vitro cell model using the SH-SY5Y cell line was analyzed before and after differentiation, induced by trans-retinoic acid and B27 supplement. Fibrillation with Aβ25–35 peptide fragment was carried out after differentiation. Cytotoxicity on undifferentiated cells and neurons was evaluated by reducing the redox potential of the MTT assay. TUNEL assay evaluates cell apoptosis by flow cytometry after B12 vitamers, folic acid, and DHA treatment. RESULTS: Supplemented cells with DHA (100 to 400 µM) showed an accented decline in cellular viability, below 10% at 400 µM. DHA IC50 at 344 µM was achieved after 24 h, 309 µM at 48 h, and 291 µM at 72 h. For Cyanocobalamin (CNC), dosages of 0.0045 to 0.072 µg/µl were not toxic, with a constant growth from 24 h to 72 h. CNC increase cell viability to 117 ± 3% at 48 h with 0.045 µg/µl and 82 ± 2% at 0.072 µg/µl. Methylcobalamin presents cell viability to 74 ± 6%, at 0.072 µg/µl after 24 h and 94 ± 5% is observed after 48 h. Folic acid concentrations of 0.1 and 0.5 µg/µl reveal cell viability of 94 ± 5% after 24, 48, and 72 h. Preliminary results from the TUNEL assay indicate a reduction in the level of apoptosis with supplementation for all micronutrients. CONCLUSIONS: Our results highlight the importance of vitamin B12, folates, and DHA for proper cerebral cell development and renewal. Furthermore, these founds indicate that well-addressed in vitro studies remain valuable tools to confirm if beneficial effects depend on the dose and frequency of intake of these specific nutrients. FUNDING SOURCES: NewFood4Thought PTDC/SAUNUT/30,455/2017.
format Online
Article
Text
id pubmed-9194004
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91940042022-06-14 Vitamin B12, Folates, and Docosahexaenoic Acid on the Prevention of Neuronal Dysfunction Motta, Carla Furtado, José Rego, Andreia Cardoso, Carlos Afonso, Claúdia Bandarra, Narcisa Prates, José Castanheira, Isabel Curr Dev Nutr Vitamins and Minerals OBJECTIVES: Global aging increases cognitive pathologies; however, some individuals present earlier symptoms with an etiology independent of age. A possible cause is the increased oxidative stress with the formation of amyloid fibrils in the neuronal tissue (in particular Aβ(1–40|42)). Studies use Aβ(25–35) fragment to form β sheet fibrils with a toxicity similar to Aβ(1–40|42). Converging studies sustain the idea that B12, B9, and docosahexaenoic may preserve regular neuronal activity. However, the literature is scarce about their synergy effects. The study aims to verify the hypothesis of reducing cellular apoptosis, using B12, B9, and docosahexaenoic acid (DHA) as preventives, isolated or in synergy, on delaying neuronal dysfunction, using “in vitro” assays. METHODS: An In vitro cell model using the SH-SY5Y cell line was analyzed before and after differentiation, induced by trans-retinoic acid and B27 supplement. Fibrillation with Aβ25–35 peptide fragment was carried out after differentiation. Cytotoxicity on undifferentiated cells and neurons was evaluated by reducing the redox potential of the MTT assay. TUNEL assay evaluates cell apoptosis by flow cytometry after B12 vitamers, folic acid, and DHA treatment. RESULTS: Supplemented cells with DHA (100 to 400 µM) showed an accented decline in cellular viability, below 10% at 400 µM. DHA IC50 at 344 µM was achieved after 24 h, 309 µM at 48 h, and 291 µM at 72 h. For Cyanocobalamin (CNC), dosages of 0.0045 to 0.072 µg/µl were not toxic, with a constant growth from 24 h to 72 h. CNC increase cell viability to 117 ± 3% at 48 h with 0.045 µg/µl and 82 ± 2% at 0.072 µg/µl. Methylcobalamin presents cell viability to 74 ± 6%, at 0.072 µg/µl after 24 h and 94 ± 5% is observed after 48 h. Folic acid concentrations of 0.1 and 0.5 µg/µl reveal cell viability of 94 ± 5% after 24, 48, and 72 h. Preliminary results from the TUNEL assay indicate a reduction in the level of apoptosis with supplementation for all micronutrients. CONCLUSIONS: Our results highlight the importance of vitamin B12, folates, and DHA for proper cerebral cell development and renewal. Furthermore, these founds indicate that well-addressed in vitro studies remain valuable tools to confirm if beneficial effects depend on the dose and frequency of intake of these specific nutrients. FUNDING SOURCES: NewFood4Thought PTDC/SAUNUT/30,455/2017. Oxford University Press 2022-06-14 /pmc/articles/PMC9194004/ http://dx.doi.org/10.1093/cdn/nzac074.022 Text en © The Author 2022. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Vitamins and Minerals
Motta, Carla
Furtado, José
Rego, Andreia
Cardoso, Carlos
Afonso, Claúdia
Bandarra, Narcisa
Prates, José
Castanheira, Isabel
Vitamin B12, Folates, and Docosahexaenoic Acid on the Prevention of Neuronal Dysfunction
title Vitamin B12, Folates, and Docosahexaenoic Acid on the Prevention of Neuronal Dysfunction
title_full Vitamin B12, Folates, and Docosahexaenoic Acid on the Prevention of Neuronal Dysfunction
title_fullStr Vitamin B12, Folates, and Docosahexaenoic Acid on the Prevention of Neuronal Dysfunction
title_full_unstemmed Vitamin B12, Folates, and Docosahexaenoic Acid on the Prevention of Neuronal Dysfunction
title_short Vitamin B12, Folates, and Docosahexaenoic Acid on the Prevention of Neuronal Dysfunction
title_sort vitamin b12, folates, and docosahexaenoic acid on the prevention of neuronal dysfunction
topic Vitamins and Minerals
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194004/
http://dx.doi.org/10.1093/cdn/nzac074.022
work_keys_str_mv AT mottacarla vitaminb12folatesanddocosahexaenoicacidonthepreventionofneuronaldysfunction
AT furtadojose vitaminb12folatesanddocosahexaenoicacidonthepreventionofneuronaldysfunction
AT regoandreia vitaminb12folatesanddocosahexaenoicacidonthepreventionofneuronaldysfunction
AT cardosocarlos vitaminb12folatesanddocosahexaenoicacidonthepreventionofneuronaldysfunction
AT afonsoclaudia vitaminb12folatesanddocosahexaenoicacidonthepreventionofneuronaldysfunction
AT bandarranarcisa vitaminb12folatesanddocosahexaenoicacidonthepreventionofneuronaldysfunction
AT pratesjose vitaminb12folatesanddocosahexaenoicacidonthepreventionofneuronaldysfunction
AT castanheiraisabel vitaminb12folatesanddocosahexaenoicacidonthepreventionofneuronaldysfunction